Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 25 of 134  Show
  1. 1
    "Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene."
    Flamez D., van Breusegem A., Scrocchi L.A., Quartier E., Pipeleers D., Drucker D.J., Schuit F.
    Diabetes 47:646-652(1998) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY.
    Category: Function, Subcellular Location, Expression, Sequences.
    Tissue: Lung.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is mapped to 2 other entries.

  2. 2
    "Quantitative trait loci for carbohydrate and total energy intake on mouse chromosome 17: congenic strain confirmation and candidate gene analyses (Glo1, Glp1r)."
    Kumar K.G., Poole A.C., York B., Volaufova J., Zuberi A., Richards B.K.
    Am. J. Physiol. 292:R207-R216(2007) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Strain: C57BL/6J.
    Tissue: Intestine.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 1 and mapped to 12 other entries.

  3. 3
    "Identification and characterization of glucagon-like peptide-1 receptors in a pituitary ACTH-secreting cell line."
    Watanabe K., Doran A.C., Tibaduiza E.C., Chen C., Beinborn M.
    Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases
    Cited for: NUCLEOTIDE SEQUENCE [MRNA].
    Category: Sequences.
    Strain: LAF1.
    Tissue: Pituitary.
    Source: UniProtKB/Swiss-Prot (reviewed).
  4. 4
    Category: Sequences.
    Strain: C57BL/6J.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 41312 other entries.

  5. 5
    "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
    The MGC Project Team
    Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
    Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
    Category: Sequences.
    Tissue: Brain.
    Source: UniProtKB/Swiss-Prot (reviewed).

    This publication is cited by 50481 other entries.

  6. 6
    "Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype."
    Flamez D., Gilon P., Moens K., Van Breusegem A., Delmeire D., Scrocchi L.A., Henquin J.C., Drucker D.J., Schuit F.
    Diabetes 48:1979-1986(1999) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 3 other entries.

  7. 7
    "Targeted gene disruption in endocrine research--the case of glucagon-like peptide-1 and neuroendocrine function."
    Seeley R.J., Woods S.C., D'Alessio D.
    Endocrinology 141:473-475(2000) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 3 other entries.

  8. 8
    "Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling."
    MacLusky N.J., Cook S., Scrocchi L., Shin J., Kim J., Vaccarino F., Asa S.L., Drucker D.J.
    Endocrinology 141:752-762(2000) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 3 other entries.

  9. 9
    "Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action."
    Scrocchi L.A., Hill M.E., Saleh J., Perkins B., Drucker D.J.
    Diabetes 49:1552-1560(2000) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 8 other entries.

  10. 10
    "Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling."
    Lovshin J., Estall J., Yusta B., Brown T.J., Drucker D.J.
    J. Biol. Chem. 276:21489-21499(2001) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is cited by 1 and mapped to 8 other entries.

  11. 11
    "Development and characterization of a glucagon-like peptide 1-albumin conjugate: the ability to activate the glucagon-like peptide 1 receptor in vivo."
    Kim J.G., Baggio L.L., Bridon D.P., Castaigne J.P., Robitaille M.F., Jette L., Benquet C., Drucker D.J.
    Diabetes 52:751-759(2003) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 9 other entries.

  12. 12
    "Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells."
    Suzuki A., Nakauchi H., Taniguchi H.
    Proc. Natl. Acad. Sci. U.S.A. 100:5034-5039(2003) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 26 other entries.

  13. 13
    "Cardiac function in mice lacking the glucagon-like peptide-1 receptor."
    Gros R., You X., Baggio L.L., Kabir M.G., Sadi A.M., Mungrue I.N., Parker T.G., Huang Q., Drucker D.J., Husain M.
    Endocrinology 144:2242-2252(2003) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 3 other entries.

  14. 14
    "Glucagon-like peptide-1 receptor is involved in learning and neuroprotection."
    During M.J., Cao L., Zuzga D.S., Francis J.S., Fitzsimons H.L., Jiao X., Bland R.J., Klugmann M., Banks W.A., Drucker D.J., Haile C.N.
    Nat. Med. 9:1173-1179(2003) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 5 other entries.

  15. 15
    "Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors."
    Preitner F., Ibberson M., Franklin I., Binnert C., Pende M., Gjinovci A., Hansotia T., Drucker D.J., Wollheim C., Burcelin R., Thorens B.
    J. Clin. Invest. 113:635-645(2004) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 5 other entries.

  16. 16
    "Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors."
    Hansotia T., Baggio L.L., Delmeire D., Hinke S.A., Yamada Y., Tsukiyama K., Seino Y., Holst J.J., Schuit F., Drucker D.J.
    Diabetes 53:1326-1335(2004) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 7 other entries.

  17. 17
    "Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure."
    Baggio L.L., Huang Q., Brown T.J., Drucker D.J.
    Gastroenterology 127:546-558(2004) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 7 other entries.

  18. 18
    "The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: differential effects in rats and mice."
    Lachey J.L., D'Alessio D.A., Rinaman L., Elmquist J.K., Drucker D.J., Seeley R.J.
    Endocrinology 146:458-462(2005) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 5 other entries.

  19. 19
    "beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1."
    Li Y., Cao X., Li L.X., Brubaker P.L., Edlund H., Drucker D.J.
    Diabetes 54:482-491(2005) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 5 other entries.

  20. 20
    "Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage."
    Knauf C., Cani P.D., Perrin C., Iglesias M.A., Maury J.F., Bernard E., Benhamed F., Gremeaux T., Drucker D.J., Kahn C.R., Girard J., Tanti J.F., Delzenne N.M., Postic C., Burcelin R.
    J. Clin. Invest. 115:3554-3563(2005) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 12 other entries.

  21. 21
    "Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor."
    Cani P.D., Knauf C., Iglesias M.A., Drucker D.J., Delzenne N.M., Burcelin R.
    Diabetes 55:1484-1490(2006) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 3 other entries.

  22. 22
    "Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure."
    Hansotia T., Maida A., Flock G., Yamada Y., Tsukiyama K., Seino Y., Drucker D.J.
    J. Clin. Invest. 117:143-152(2007) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 5 other entries.

  23. 23
    "BMP4-BMPR1A signaling in beta cells is required for and augments glucose-stimulated insulin secretion."
    Goulley J., Dahl U., Baeza N., Mishina Y., Edlund H.
    Cell Metab. 5:207-219(2007) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 127 other entries.

  24. 24
    "GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion."
    Cani P.D., Holst J.J., Drucker D.J., Delzenne N.M., Thorens B., Burcelin R., Knauf C.
    Mol. Cell. Endocrinol. 276:18-23(2007) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 21 other entries.

  25. 25
    "Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice."
    Flock G., Baggio L.L., Longuet C., Drucker D.J.
    Diabetes 56:3006-3013(2007) [PubMed] [Europe PMC] [Abstract]
    Source: MGI:99571.

    This publication is mapped to 5 other entries.

1 to 25 of 134  Show

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health